Anti-Inflammatory Therapeutics Market Performance and Future Outlook at 4.9% CAGR Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the anti-inflammatory therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Anti-Inflammatory Therapeutics Industry By 2029?

The anti-inflammatory therapeutics market has shown consistent expansion in recent years. It is expected to expand from $114.71 billion in 2024 to $117.28 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.2%. This historical growth can be attributed to the prevalence of chronic diseases, an aging population, greater awareness, and government initiatives.

The anti-inflammatory therapeutics market is projected to experience consistent expansion over the upcoming years. This market is predicted to reach $142.15 billion by 2029, achieving a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast period include pioneering therapies, rising healthcare spending, a greater emphasis on rare diseases, and the development of biologics and biosimilars. Key trends anticipated within this period involve progress in immunotherapy, the application of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the broadening of approved indications.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

What Major Drivers Are Impacting The Anti-Inflammatory Therapeutics Market?

The rising occurrence of inflammatory bowel disease is anticipated to boost the expansion of the anti-inflammatory therapeutics market in the future. Inflammatory bowel disease (IBD) is defined as a persistent condition characterized by inflammation within the gastrointestinal tract. Anti-inflammatory therapeutics are vital for managing Crohn’s disease, as they work to diminish inflammation, control disease symptoms, and lower surgical risk. As an illustration, data from July 2023, provided by Oxford University Press (OUP), the university press of the University of Oxford, indicated that the incidence of inflammatory bowel disease (IBD) stands at 10.9 per 100,000 person-years, with a prevalence of 721 per 100,000 people. Consequently, the growing prevalence of inflammatory bowel disease is a key factor propelling the anti-inflammatory therapeutics market’s expansion.

Which Segment Categories Are Driving Maximum Growth In The Anti-Inflammatory Therapeutics Market?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Which Long-Term Trends Will Play A Crucial Role In The Anti-Inflammatory Therapeutics Market?

Leading companies active in the anti-inflammatory therapeutics market are introducing new and innovative drugs to solidify their market position. For example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology firm, and Sanofi, a France-based pharmaceutical and healthcare entity, introduced Kevzara (sarilumab). This medication is the initial and exclusive anti-inflammatory biologic specifically recommended for adult patients with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition, who either do not adequately respond to corticosteroids or are unable to tolerate corticosteroid tapering.

Who Are The Dominant Players In The Anti-Inflammatory Therapeutics Market Today?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Region Is At The Forefront Of Innovation In The Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Non Steroidal Anti Inflammatory Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Cystic Fibrosis Cf Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795